Mumbai, 3 November 2016 (GPN) : Incorporated in 2005, GreenSignal Bio Pharma is Chennai based pharmaceutical company engaged in the development, manufacture and sale of the BCG vaccine. source GPN network, India’s fastest online news network. GreenSignal is an Indian vaccine manufacturing company with global operations. The products company manufacture includes a BCG vaccine and BCG-ONCO, an immunotherapy drug. The immunotherapy drug is used in the treatment of urinary bladder cancer.
Both vaccines produced by GreenSignal are generic drugs and company do not require any patents for the same.
GreenSignal has a long term contract with UNICEF to supply the BCG vaccine to UNICEF. GreenSignal is among 4 companies worldwide who have been WHO-prequalified to supply the BCG vaccine to UNICEF. Other customers include Indonesia, Nepal and Ministry of Health, India.
GreenSignal Pharma business is organized into domestic and international operations. For FY 2016, GreenSignal’s domestic and international operations accounted for 53.79% and 46.20%, respectively, of its net revenues from operations.
GreenSignal Bio have a manufacturing facility located at Pappankuppam Village, Gummidipoondi, Tiruvallur District, Tamil Nadu.
Company Promoters:
The promoters of the company are:
1. Mr P. Sundaraparipooranan
2. Dr. P. Murali
Company Financials:
Objects of the Issue:
The objects of the Offer are to:
1. Achieve the benefits of listing the Equity Shares on the BSE and the NSE;
2. To carry out the sale of up to 14,579,560 Equity Shares by the Selling Shareholders;
3. Enhance visibility and brand image among existing and potential customers; and
4. Provide liquidity to the existing shareholders.
Issue Detail:
Issue Open: Nov 9, 2016 – Nov 11, 2016
Issue Type: Book Built Issue IPO
Issue Size:
Offer for Sale of 14,579,560 Equity
Shares of Rs 10 aggregating up to Rs [.] Cr
Face Value: Rs 10 Per Equity Share.
Issue Price: Rs. 76 – Rs. 80 Per Equity Share
Market Lot: 175 Shares
Minimum Order Quantity: 175 Shares
Listing At: BSE, NSE.
